Pharmacy

Spravato — Miracle Drug or False Hope?

For nearly thirty years, the FDA had not approved any new antidepressant medications since Prozac entered the market in 1988.


Mitigation of Medical Malpractice Risk Stemming from the Prescription of Psychotropic Medication

Physicians may be sued for medical negligence based on a lack of informed consent if they prescribe medication without providing the patient with sufficient information to make an informed decision about whether to use the drug. Informed consent discussions may be particularly important when...


Off-label Use of Newer Anticoagulants — What Should a Patient Be Told?

In recent years, new anticoagulants such as Pradaxa (dabigatran), Xarelto (rivaroxaban) and Eliquis (apixaban) have been approved by the FDA. They have benefits over older drugs such as Coumadin (warfarin), as they do not require frequent blood monitoring. Apart from their FDA-approved uses, these drugs are being used “off-label” to address conditions for which they have not been formally tested.